The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 20, 2007

Filed:

Feb. 11, 2002
Applicants:

Debra Hudson, Livermore, CA (US);

Marcus A. Van Dijk, Bilthoven, NL;

Jan G. J. Van DE Winkel, Odijk, NL;

Inventors:

Debra Hudson, Livermore, CA (US);

Marcus A. van Dijk, Bilthoven, NL;

Jan G. J. van de Winkel, Odijk, NL;

Assignee:

Medarex, Inc., Princeton, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/40 (2006.01); A61K 39/42 (2006.01); C12N 5/00 (2006.01); C07K 16/00 (2006.01); C12P 21/08 (2006.01);
U.S. Cl.
CPC ...
Abstract

Human monoclonal antibodies which bind specifically to Fc alpha receptor (CD89), including monoclonal antibodies which react specifically to Fc receptor for IgA of human effector cells are disclosed. The binding agents, e.g., antibodies are useful for targeting human effector cells (e.g. macrophages) against a target cell (e.g. a cancer cell, an infectious agent, etc.). For this purpose, bifunctional antibodies or heteroantibodies can be constructed containing the binding region derived from an anti-Fc-alpha receptor antibody and the binding region of a target-specific antibody. Targeted effector cells can specifically lyse target cells.


Find Patent Forward Citations

Loading…